Natco Pharma Limited CC-Dec24.pdf
13 Feb 2025
-
Yes, thanks for taking the question. A couple of things. One is Revlimid, can you throw some light on volume, market share currently we have?
Read in transcript -
And that will start from the next quarter itself.
Read in transcript -
This quarter, yes, sorry. And second, can you also throw some light on the settlement, especially on the GLP-1 opportunity? I know we are tied up with Mylan and we have settled with N ovo. But what is the total opportunity size for us and where are we? Is there any potential launch possible in 2026 in India?
Read in transcript